T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.82B | |
| 2 | +$1.38B | |
| 3 | +$1.16B | |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| 1 | +$4.73B | |
| 2 | +$3.54B | |
| 3 | +$1.75B | |
| 4 |
Amphenol
APH
|
+$1.65B |
| 5 |
KLA
KLAC
|
+$1.5B |
Sector Composition
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SION
926
Sionna Therapeutics
SION
$1.63B
| $30.3M | ﹤0.01% |
756,376
-74,997
|
|
||
927
Performance Food Group
PFGC
$16.3B
| $30.3M | ﹤0.01% |
353,174
-64,603
|
|
||
928
Constellation Brands
STZ
$24.5B
| $30.2M | ﹤0.01% |
201,481
-9,668
|
|
||
929
Celsius Holdings
CELH
$7.26B
| $30.2M | ﹤0.01% |
850,606
+197,134
|
|
||
930
Cirrus Logic
CRUS
$8.22B
| $30.1M | ﹤0.01% |
208,382
-68,172
|
|
||
931
Coca-Cola Europacific Partners
CCEP
$43.3B
| $30.1M | ﹤0.01% |
331,689
+43,511
|
|
||
932
Arcosa
ACA
$6.23B
| $30M | ﹤0.01% |
282,398
+154,201
|
|
||
933
IES Holdings
IESC
$14.6B
| $29.7M | ﹤0.01% |
62,236
+1,415
|
|
||
934
Hims & Hers Health
HIMS
$6.68B
| $29.4M | ﹤0.01% |
1,417,344
+690,857
|
|
||
935
Gen Digital
GEN
$14.4B
| $29.4M | ﹤0.01% |
1,561,870
-411,669
|
|
||
936
Erasca
ERAS
$4.36B
| $29.4M | ﹤0.01% |
1,815,340
+1,711,837
|
|
||
937
Leidos
LDOS
$15.4B
| $29M | ﹤0.01% |
186,749
-94,714
|
|
||
938
Centrus Energy
LEU
$3.12B
| $29M | ﹤0.01% |
167,195
-204,627
|
|
||
939
Cullinan Oncology
CGEM
$798M
| $28.8M | ﹤0.01% |
2,029,719
+1,982,532
|
|
||
940
Vita Coco
COCO
$4.49B
| $28.7M | ﹤0.01% |
598,008
-550,445
|
|
||
941
Pinnacle Financial Partners Inc
PNFP
$14.2B
| $28.6M | ﹤0.01% |
331,467
+263,982
|
|
||
942
BJs Wholesale Club
BJ
$11.6B
| $28.5M | ﹤0.01% |
289,845
-122,360
|
|
||
943
General Mills
GIS
$18B
| $28.4M | ﹤0.01% |
763,206
-133,393
|
|
||
944
Atour Lifestyle Holdings
ATAT
$4.54B
| $28.3M | ﹤0.01% |
767,459
+719,376
|
|
||
945
Golar LNG
GLNG
$5.14B
| $28.1M | ﹤0.01% |
519,758
+463,565
|
|
||
946
Kraft Heinz
KHC
$28.7B
| $28.1M | ﹤0.01% |
1,249,298
-11,924
|
|
||
947
W.R. Berkley
WRB
$25.1B
| $28M | ﹤0.01% |
423,154
-5,092
|
|
||
|
AKTS
948
Aktis Oncology
AKTS
$1.08B
| $28M | ﹤0.01% |
+1,564,196
|
|
||
949
Zoom
ZM
$27.1B
| $27.9M | ﹤0.01% |
347,433
+88,353
|
|
||
950
Okta
OKTA
$20.4B
| $27.8M | ﹤0.01% |
353,297
-355,067
|
|